Another promising ADC target is trophoblast cell surface antigen (Trop2), which is a transmembrane glycoprotein calcium signal transducer and is overexpressed in over 60% of adenocarcinomas and 75% of squamous cell carcinoma (NSCLC). The gene discussed is TACSTD2; the disease is non-small cell lung carcinoma.